ARTICLE | Company News
FDA delays PDUFA for Delcath's chemosaturation system
April 11, 2013 12:34 AM UTC
Delcath Systems Inc. (NASDAQ:DCTH) said FDA extended the PDUFA date by three months for an NDA for Melblez Kit chemosaturation system, which delivers melphalan to treat unresectable ocular melanoma th...